GB9610341D0 - Formulation for inhalation - Google Patents

Formulation for inhalation

Info

Publication number
GB9610341D0
GB9610341D0 GB9610341A GB9610341A GB9610341D0 GB 9610341 D0 GB9610341 D0 GB 9610341D0 GB 9610341 A GB9610341 A GB 9610341A GB 9610341 A GB9610341 A GB 9610341A GB 9610341 D0 GB9610341 D0 GB 9610341D0
Authority
GB
Grant status
Grant
Patent type
Prior art keywords
inhalation
formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9610341A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Andaris Ltd
Original Assignee
Andaris Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Grant date

Links

GB9610341A 1996-05-17 1996-05-17 Formulation for inhalation Pending GB9610341D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9610341A GB9610341D0 (en) 1996-05-17 1996-05-17 Formulation for inhalation

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
GB9610341A GB9610341D0 (en) 1996-05-17 1996-05-17 Formulation for inhalation
PCT/GB1997/001309 WO1997044012A1 (en) 1996-05-17 1997-05-14 Formulation comprising microparticles, for inhalation
AU2783897A AU2783897A (en) 1996-05-17 1997-05-14 Formulation comprising microparticles, for inhalation
JP54176697A JP2000512268A (en) 1996-05-17 1997-05-14 Inhalable particulate containing formulations
CA 2253478 CA2253478A1 (en) 1996-05-17 1997-05-14 Formulation comprising microparticles, for inhalation
KR19987009170A KR20000011020A (en) 1996-05-17 1997-05-14 Formulation comprising microparticles, for inhalation
AR007178A1 AR007178A1 (en) 1996-05-17 1997-05-16 Formulation containing microparticles for inhalation
ZA9704328A ZA9704328B (en) 1996-05-17 1997-05-19 Formulation comprising microparticles, for inhalation.
NO985341A NO985341A (en) 1996-05-17 1998-11-16 Formulation comprising microparticles for inhalation

Publications (1)

Publication Number Publication Date
GB9610341D0 true GB9610341D0 (en) 1996-07-24

Family

ID=10793869

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9610341A Pending GB9610341D0 (en) 1996-05-17 1996-05-17 Formulation for inhalation

Country Status (5)

Country Link
JP (1) JP2000512268A (en)
KR (1) KR20000011020A (en)
CA (1) CA2253478A1 (en)
GB (1) GB9610341D0 (en)
WO (1) WO1997044012A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6086376A (en) * 1998-01-30 2000-07-11 Rtp Pharma Inc. Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
DK1107743T3 (en) * 1998-08-25 2007-10-22 Advanced Inhalation Res Inc Stable, spraytörrede protein formulations
EP1767195A3 (en) * 1998-08-25 2007-04-04 Advanced Inhalation Research, Inc. Stable spray-dried protein formulations
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB9107628D0 (en) * 1991-04-10 1991-05-29 Moonbrook Limited Preparation of diagnostic agents
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
GB9410222D0 (en) * 1994-05-21 1994-07-06 Glaxo Wellcome Australia Ltd Medicaments

Also Published As

Publication number Publication date Type
CA2253478A1 (en) 1997-11-27 application
WO1997044012A1 (en) 1997-11-27 application
KR20000011020A (en) 2000-02-25 application
JP2000512268A (en) 2000-09-19 application

Similar Documents

Publication Publication Date Title
US5797392C1 (en) Inhaler
GB2337461B (en) Formulation
GB2308992B (en) Nebulizer
GB2344534B (en) Inhalation apparatus
GB9606586D0 (en) Pharmaceutical compositions
GB9606429D0 (en) Pharmaceutical compositions
GB9608719D0 (en) Pharmaceutical compositions
GB9603942D0 (en) Pharmaceutical compositions
GB9601042D0 (en) Medical use
GB9606686D0 (en) Medical use
GB9626920D0 (en) Medical use
GB9710866D0 (en) Inhaler device
CA81141S (en) Inhaler device
GB9820525D0 (en) Formulation
GB9823645D0 (en) Formulation
GB9620880D0 (en) Therapeutic use
GB9620777D0 (en) Therapeutic use
GB9605465D0 (en) Therapeutic use